InsightRX Competitors and Similar CompaniesClear all
Karyopharm Therapeutics's competitors and similar companies include STADA.
 Karyopharm Therapeutics Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies. | ||
Founding Date | Founding Date 2008 | Founding Date 1895 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Newton, US HQ Givatayim, IL | Locations Bad Vilbel, DE HQ Beijing, CN Hangzhou Shi, CN Shanghai, CN Bad Vilbel, DE Budapest, HU Vilnius, LT see more |
Employees | Employees 22818% decrease | Employees 12,33911% increase |
Valuation ($) | Valuation ($) 111.7 m | Valuation ($) 6 b |
Financial | ||
Revenue (est.) | Revenue (est.) $146.1m (FY, 2025) | Revenue (est.) €3b (FY, 2020) |
Cost of goods | Cost of goods $5.9m (FY, 2025) | Cost of goods €1.3b (FY, 2020) |
Gross profit | Gross profit $140.1m (FY, 2025) | Gross profit €1.7b (FY, 2020) |
Net income | Net income ($196m) (FY, 2025) | Net income €181.9m (FY, 2020) |
For sources of this data, please see the company profile
View Company Profiles
STADA
HQ
Bad Vilbel, DE
Employees
12,339↑ 11% increase
STADA Arzneimittel is a company engaged in the healthcare and pharmaceuticals business.
View company